(Q54391325)

29 May 2018

title

Role of polymorphic N-acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis. (English)

1 reference

29 May 2018

author name string

Purabi Deka Bose

1

1 reference

29 May 2018

Manash Pratim Sarma

2

1 reference

29 May 2018

Subhash Medhi

3

1 reference

29 May 2018

Bhudev Chandra Das

4

1 reference

29 May 2018

Syed Akhtar Husain

5

1 reference

29 May 2018

Premashis Kar

6

1 reference

29 May 2018

publication date

1 February 2011

1 reference

29 May 2018

Journal of Gastroenterology and Hepatology

published in

1 reference

29 May 2018

volume

26

1 reference

29 May 2018

page(s)

312-318

1 reference

29 May 2018

issue

2

1 reference

29 May 2018

Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06355.X

Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06355.X

Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06355.X

Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06355.X

Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06355.X

Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06355.X

Molecular mechanism of slow acetylation of drugs and carcinogens in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06355.X

Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06355.X

Short-course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin. Community physicians' seven-year experience with mainly outpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06355.X

Criteria of drug-induced liver disorders. Report of an international consensus meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06355.X

Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06355.X

Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06355.X

Association studies of polymorphisms of CYP2E1 gene in alcoholics with cirrhosis, antisocial personality, and normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06355.X

Monitoring and management of antituberculosis drug induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06355.X

10.1111/J.1440-1746.2010.06355.X

21 January 2018

Identifiers

DOI

1 reference

29 May 2018

PubMed ID

21261721

1 reference

29 May 2018